HCID 86603578, compound → HCID 11162908, compound
Reaction equation
[CH2:1]([C:8]1[O:12][C:11]([C@H:13]([CH2:26][CH2:27][CH2:28][CH2:29][CH3:30])[CH2:14][N:15]([O:18]CC2C=CC=CC=2)[CH:16]=[O:17])=[N:10][N:9]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1>[Pd]>[CH2:1]([C:8]1[O:12][C:11]([C@H:13]([CH2:26][CH2:27][CH2:28][CH2:29][CH3:30])[CH2:14][N:15]([OH:18])[CH:16]=[O:17])=[N:10][N:9]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1Participants
3
Reactant 1
Product 1
Reagents, catalysts & solvents 1
Procedure
A mixture consisting of N-[(R)-2-(5-benzyl-[1,3,4]oxadiazol-2-yl)-heptyl]-N-benzyloxy formamide (108 mg crude) with 10% palladium on carbon was stirred under an atmosphere of hydrogen for 5.5 h. The mixture was filtered and solvent removed in vacuo. Purification by preparative HPLC provided the title compound (30 mg, 38% for two steps). Mass spectrum ES+: 318 [M+H]+
Workup
- filtrationThe mixture was filtered
- customsolvent removed in vacuo
- customPurification by preparative HPLC
Sources & evidence
- ORD record
- ord-b022e8a78dce4294a83b38476f9bd5e7
- Source dataset
- uspto-grants-2007_01
- Patent number
- US07166624B2
Reaction notes
Loading…